You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of study population by TyG index quartile

From: The association between the triglyceride–glucose index and vulnerable plaques in patients with type 2 diabetes mellitus: insights from coronary computed tomography angiography

 

T1(n = 514)

T2(n = 514)

T3(n = 514)

T4(n = 514)

p

Variables clinical parameters

Age, years

70.44 ± 9.71

69.25 ± 9.33

68.43 ± 10.44a

65.54 ± 11.29 abc

 < 0.001

Male, n (%)

329(64%)

310(60%)

315(61%)

320(62%)

0.673

Height, cm

162.7 ± 8.30

162.54 ± 8.59

162.35 ± 9.53

162.63 ± 10.93

0.938

Weight, kg

62.84 ± 10.90

64.45 ± 12.19 a

65.91 ± 12.43a

69.52 ± 14.39 abc

 < 0.001

BMI, kg/m2

23.66 ± 3.22

24.31 ± 3.65

25.49 ± 16.09a

27.52 ± 23.05 abc

 < 0.001

SBP, mmHg

136.21 ± 19.74

136.05 ± 19.66

137.25 ± 19.84

138.04 ± 19.9

0.330

DBP, mmHg

77.19 ± 11.46

78.21 ± 11.85

79.77 ± 12.21ab

82.12 ± 12.14 abc

 < 0.001

Hypertension, n (%)

242(47%)

236(46%)

250(49%)

263(51%)

0.324

Dyslipidemia, n (%)

173(34%)

240(47%) a

306(60%) ab

430(84%) abc

 < 0.001

Symptomatic CVD

95(18%)

91(18%)

94(18%)

96(19%)

0.980

Smoking history

188(37%)

172(33%)

209(41%)

189(37%)

0.124

Drinking history

129(25%)

130(25%)

146(28%)

140(27%)

0.572

Use of statin, n (%)

237(46%)

200(39%)a

193(38%) a

218(42%)

0.025

Use of antidiabetic agents (n%)

356(68%)

344(67%)

372(72%)

366(71%)

0.460

Biguanides, n (%)

141(27%)

140(26%)

157(31%)

161(31%)

0.456

Insuin, n (%)

141(27%)

136(26%)

158(31%)

149(29%)

0.395

α-Glucosidase inhibitor, n (%)

117(23%)

101(20%)

102(20%)

76(15%) a

0.013

Other oral, n (%)

142(28%)

110(23%)

118(23%)

85(17%) a

0.005

Biochemical parameters

TyG index

8.19 ± 0.28

8.74 ± 0.12a

9.16 ± 0.13ab

9.91 ± 0.44 abc

 < 0.001

Glycemia, mg/dl

102.04 ± 23.96

117.88 ± 24.10a

128.62 ± 28.10ab

142.35 ± 28.15 abc

 < 0.001

TG, mg/dl

73.39 ± 20.43

103.52 ± 22.31a

137.46 ± 32.74ab

244.03 ± 109.41 abc

 < 0.001

TC, mmol/L

3.63 ± 0.97

3.96 ± 1.00a

4.18 ± 1.18ab

4.56 ± 1.15 abc

 < 0.001

HDL, mg/dl

1.29 ± 0.36

1.20 ± 0.33a

1.11 ± 0.33ab

0.98 ± 0.28 abc

 < 0.001

LDL, mg/dl

2.02 ± 0.79

2.31 ± 0.87a

2.50 ± 1.01ab

2.57 ± 0.95ab

 < 0.001

UREA, mg/dl

6.12 ± 3.15

6.00 ± 2.64

6.42 ± 4.10

6.43 ± 4.68

0.166

Cr, mg/dl

83.79 ± 72.15

82.08 ± 60.48

88.29 ± 71.72

89.55 ± 77.15

0.276

CysC, mg/dl

1.14 ± 0.68

1.17 ± 0.76

1.21 ± 0.83

1.22 ± 0.90

0.375

CK, IU/L

100.85 ± 106.13

111.06 ± 196.74

116.31 ± 243.85

96.34 ± 110.29

0.242

LDH, IU/L

175.77 ± 50.30

179.36 ± 61.20

180.88 ± 63.42

173.55 ± 53.02

0.141

  1. Data are presented as mean ± SD or number (percentage)
  2. BMI Body mass index, SBP Systolic blood pressure, DBP Diastolic blood pressure, TG Triglycerides, TC Total cholesterol, HDL High-density lipoprotein, LDL Low-density lipoprotein, CysC Cystatin C, CK Creatine kinase, LDH Lactate dehydrogenase
  3. P values in bold are < 0.05
  4. a adjuted P < 0.05 vs. T1
  5. b adjuted P < 0.05 vs. T2
  6. c adjuted P < 0.05 vs. T3